AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.564
-0.016 (-2.76%)
Nov 20, 2024, 4:00 PM EST - Market closed
AEON Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 3.44 | 5.16 | 9.75 | 5.13 | 20.17 | 6.32 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 105.42 | Upgrade
|
| Cash & Short-Term Investments | 3.44 | 5.16 | 9.75 | 5.13 | 20.17 | 111.75 | Upgrade
|
| Cash Growth | 32.23% | -47.08% | 90.05% | -74.57% | -81.95% | 17.47% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 0.27 | Upgrade
|
| Receivables | - | - | - | - | - | 0.27 | Upgrade
|
| Prepaid Expenses | 0.58 | 1.06 | 0.09 | 0.03 | 0.21 | 0.13 | Upgrade
|
| Total Current Assets | 4.02 | 6.22 | 9.84 | 5.15 | 20.38 | 112.15 | Upgrade
|
| Property, Plant & Equipment | 1.69 | 0.59 | 0.91 | 0.92 | - | - | Upgrade
|
| Long-Term Investments | - | - | - | - | - | 1.43 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.84 | 0.78 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.36 | - | - | Upgrade
|
| Total Assets | 5.73 | 6.85 | 10.78 | 6.44 | 21.21 | 114.35 | Upgrade
|
| Accounts Payable | 3.03 | 3.39 | 7.81 | 1.19 | 2.03 | 1.03 | Upgrade
|
| Accrued Expenses | 7.27 | 9.38 | 3.65 | 4.01 | 2.17 | 1.66 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 14.79 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 70.87 | 15.6 | - | - | Upgrade
|
| Current Portion of Leases | 0.13 | 0.28 | 0.26 | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.02 | Upgrade
|
| Total Current Liabilities | 10.43 | 13.05 | 82.57 | 20.8 | 4.2 | 17.5 | Upgrade
|
| Long-Term Debt | 13.29 | - | 60.43 | 70.76 | 72.16 | 15.16 | Upgrade
|
| Long-Term Leases | 1.26 | - | 0.24 | 0.52 | - | - | Upgrade
|
| Other Long-Term Liabilities | 8.7 | 146.84 | - | 0.22 | 10.14 | 9.62 | Upgrade
|
| Total Liabilities | 33.68 | 159.89 | 143.24 | 92.31 | 86.5 | 42.27 | Upgrade
|
| Common Stock | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 399.56 | 381.26 | 187.35 | 187.35 | 158.39 | 266.6 | Upgrade
|
| Retained Earnings | -427.51 | -473.6 | -474.84 | -422.28 | -366.65 | -333.73 | Upgrade
|
| Treasury Stock | - | - | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Comprehensive Income & Other | - | -60.71 | - | - | - | - | Upgrade
|
| Total Common Equity | -27.95 | -153.04 | -287.5 | -234.94 | -208.27 | -67.15 | Upgrade
|
| Minority Interest | - | - | 17.09 | 11.12 | 5.04 | 1.28 | Upgrade
|
| Shareholders' Equity | -27.95 | -153.04 | -132.46 | -85.88 | -65.29 | 72.08 | Upgrade
|
| Total Liabilities & Equity | 5.73 | 6.85 | 10.78 | 6.44 | 21.21 | 114.35 | Upgrade
|
| Total Debt | 14.69 | 0.28 | 131.79 | 86.89 | 72.16 | 29.95 | Upgrade
|
| Net Cash (Debt) | -11.25 | 4.88 | -122.05 | -81.76 | -51.99 | 81.79 | Upgrade
|
| Net Cash Per Share | -0.26 | 0.05 | -0.88 | -0.65 | -7.88 | 12.31 | Upgrade
|
| Filing Date Shares Outstanding | 39.52 | 39.52 | 138.83 | 138.83 | 8.17 | 6.6 | Upgrade
|
| Total Common Shares Outstanding | 39.12 | 37.16 | 138.83 | 138.83 | 6.6 | 6.6 | Upgrade
|
| Working Capital | -6.41 | -6.83 | -72.74 | -15.65 | 16.18 | 94.65 | Upgrade
|
| Book Value Per Share | -0.71 | -4.12 | -2.07 | -1.69 | -31.57 | -10.18 | Upgrade
|
| Tangible Book Value | -27.95 | -153.04 | -287.5 | -234.94 | -208.27 | -67.15 | Upgrade
|
| Tangible Book Value Per Share | -0.71 | -4.12 | -2.07 | -1.69 | -31.57 | -10.18 | Upgrade
|
| Machinery | 0.44 | 0.44 | 0.44 | 0.13 | - | - | Upgrade
|
| Leasehold Improvements | 0.07 | 0.07 | 0.07 | 0.07 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.